Literature DB >> 24060643

Expulsive therapy versus early endoscopic stone removal in patients with acute renal colic: a comparison of indirect costs.

Casey A Dauw1, Samuel R Kaufman1, Brent K Hollenbeck1, William W Roberts1, Gary J Faerber1, J Stuart Wolf1, John M Hollingsworth2.   

Abstract

PURPOSE: While medical expulsive therapy is associated with lower health care expenditures compared to early endoscopic stone removal in patients with renal colic, little is known about the effect of medical expulsive therapy on indirect costs.
MATERIALS AND METHODS: Using a previously validated claims based algorithm we identified a cohort of patients with acute renal colic. After determining the up-front treatment type (ie an initial course of medical expulsive therapy vs early endoscopic stone removal) we compared differences in rates of short-term disability filing. We used propensity score matching to account for differences between treatment groups such that patients treated with medical expulsive therapy vs early endoscopic stone removal were similar with regard to measured characteristics.
RESULTS: In total, 257 (35.8%) and 461 (64.2%) patients were treated with medical expulsive therapy or early endoscopic stone removal, respectively. There were no differences between treatment groups after propensity score matching. In the matched cohort the patients treated with medical expulsive therapy had a 6% predicted probability of filing a claim for short-term disability compared to 16.5% in the early endoscopic stone removal cohort (p <0.0001). Among the patients who filed for short-term disability those prescribed medical expulsive therapy had on average 1 fewer day of disability than those treated surgically (0.9 vs 1.8 days, p <0.001).
CONCLUSIONS: An initial trial of medical expulsive therapy is associated with significantly lower indirect costs to the patient compared to early endoscopic stone removal. These findings have implications for providers when counseling patients with acute renal colic.
Copyright © 2014 American Urological Association Education and Research, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  disability; drug therapy; insurance; operative; surgical procedures; urinary calculi

Mesh:

Substances:

Year:  2013        PMID: 24060643     DOI: 10.1016/j.juro.2013.09.028

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  12 in total

1.  The evaluation of the effectiveness of Gilaburu (Viburnum opulus L.) extract in the medical expulsive treatment of distal ureteral stones.

Authors:  Fuat Kızılay; Volkan Ülker; Orçun Çelik; Turan Özdemir; Özgür Çakmak; Ertan Can; Oktay Nazlı
Journal:  Turk J Urol       Date:  2019-04-03

2.  The economics of stone disease.

Authors:  Noah E Canvasser; Peter Alken; Michael Lipkin; Stephen Y Nakada; Hiren S Sodha; Abdulkadir Tepeler; Yair Lotan
Journal:  World J Urol       Date:  2017-01-20       Impact factor: 4.226

3.  Emergent versus delayed lithotripsy for obstructing ureteral stones: a cumulative analysis of comparative studies.

Authors:  Davide Arcaniolo; Marco De Sio; Jens Rassweiler; Jilian Nicholas; Estevão Lima; Giuseppe Carrieri; Evangelos Liatsikos; Vincenzo Mirone; Manoj Monga; Riccardo Autorino
Journal:  Urolithiasis       Date:  2017-02-23       Impact factor: 3.436

4.  Canadian Urological Association guideline: Management of ureteral calculi - Abridged version.

Authors:  Jason Y Lee; Sero Andonian; Naeem Bhojani; Jennifer Bjazevic; Ben H Chew; Shubha De; Hazem Elmansy; Andrea G Lantz-Powers; Kenneth T Pace; Trevor D Schuler; Rajiv K Singal; Peter Wang; Michael Ordon
Journal:  Can Urol Assoc J       Date:  2021-12       Impact factor: 1.862

5.  Canadian Urological Association guideline: Management of ureteral calculi - Full-text.

Authors:  Jason Y Lee; Sero Andonian; Naeem Bhojani; Jennifer Bjazevic; Ben H Chew; Shubha De; Hazem Elmansy; Andrea G Lantz-Powers; Kenneth T Pace; Trevor D Schuler; Rajiv K Singal; Peter Wang; Michael Ordon
Journal:  Can Urol Assoc J       Date:  2021-12       Impact factor: 1.862

6.  Comparison of Empiric Preventative Pharmacologic Therapies on Stone Recurrence Among Patients with Kidney Stone Disease.

Authors:  Ryan S Hsi; Phyllis L Yan; Joseph J Crivelli; David S Goldfarb; Vahakn Shahinian; John M Hollingsworth
Journal:  Urology       Date:  2022-05-08       Impact factor: 2.633

7.  Comparison of Selective vs Empiric Pharmacologic Preventive Therapy of Kidney Stone Recurrence With High-Risk Features.

Authors:  Ryan S Hsi; Phyllis L Yan; Joseph J Crivelli; David S Goldfarb; Vahakn Shahinian; John M Hollingsworth
Journal:  Urology       Date:  2022-02-17       Impact factor: 2.633

8.  Early ureteroscopic lithotripsy in acute renal colic caused by ureteral calculi.

Authors:  Ercan Ogreden; Erhan Demirelli; Mefail Aksu; Doğan Sabri Tok; Ural Oğuz
Journal:  Int Urol Nephrol       Date:  2019-10-04       Impact factor: 2.370

Review 9.  Medical and alternative therapies in urinary tract stone disease.

Authors:  Ercan Yuvanc; Erdal Yilmaz; Devrim Tuglu; Ertan Batislam
Journal:  World J Nephrol       Date:  2015-11-06

10.  Comparison of Selective Versus Empiric Pharmacologic Preventative Therapy With Kidney Stone Recurrence.

Authors:  Ryan S Hsi; Phyllis L Yan; David S Goldfarb; Ada Egbuji; Yajuan Si; Vahakn Shahinian; John M Hollingsworth
Journal:  Urology       Date:  2020-12-19       Impact factor: 2.649

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.